Court approves Bionomics' re-domiciliation; Neuphoria to list Dec 24 under NEUP

Neuphoria Therapeutics Inc.

Supreme Court of NSW approved Scheme of Arrangement on Dec 16, 2024; scheme became legally effective after lodgment with ASIC.
Bionomics ADSs trade on Nasdaq through Dec 23, 2024; shareholders as of Dec 17 record date receive scheme consideration.
Neuphoria Therapeutics Inc. shares expected to begin trading on Nasdaq under "NEUP" on Dec 24, 2024.
Bionomics will become wholly-owned subsidiary of Neuphoria, re-domiciling from Australia to Delaware.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.